Forum Topic News
  • Conversation: 'Green' Medical Propellant Receives FDA Approval to Proceed to Clinical Trials

    • February 4, 2020 5:28 PM GMT
      • Post(s)
        548

      'Green' Medical Propellant Receives FDA Approval to Proceed to Clinical Trials

      Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). Zephex® 152a reduces the carbon footprint of an MDI, helping to safeguard an invaluable therapeutic option for patients.
      Koura (previously known as Mexichem Fluor), a pioneer in the development of next generation propellants, today announced FDA approval to proceed to clinical trials with Zephex® 152a. This new medical propellant has been under development for several years for use in metered-dose inhalers (MDIs) for treatment of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). Zephex® 152a reduces the carbon footprint of an MDI, helping to safeguard an invaluable therapeutic option for patients.
      Read more: https://prn.to/3baPtvS

Add Reputation

Do you want to add reputation for this member by this post?

or cancel